Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000930 · ClinicalTrials.gov registry record

A Study of HIV in Newly Infected Individuals

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
12
Study locations

NCT00000930 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000930, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
12
Study locations

Study Summary

The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. These groups include men who have sex with men, IV drug users, and women at risk of getting HIV through heterosexual contact. Learning how HIV behaves in these populations once they become infected can help with the planning of future HIV vaccine studies.

Conditions Studied

Study Locations (12)

New York

  • New York Univ Med Ctr - New York
  • Bronx-Lebanon Hosp Ctr - The Bronx
  • New York Blood Ctr - The Bronx

California

  • Los Angeles County / Health Research Assoc / Drew Med Ctr - Los Angeles
  • San Francisco Dept of Hlth / AIDS Office - San Francisco

Colorado

  • Denver Dept of Public Health / HIVNET - Denver

Illinois

  • Univ of Illinois Chicago / Howard Brown Hlth Ctr - Chicago

Maryland

  • Johns Hopkins Univ - Baltimore

Massachusetts

  • Fenway Community Health Ctr / HIVNET - Boston

Pennsylvania

  • Univ of Pennsylvania / HIVNET - Philadelphia

Rhode Island

  • Miriam Hosp - Providence

Trial Details

FieldValue
Est. Completion 2008-05

What the Registry Record Tells You About NCT00000930

The ClinicalTrials.gov registry entry for NCT00000930 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00000930 reports 12 study locations spanning 9 distinct geographic areas - top geographies include New York, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00000930 about?

NCT00000930 is a clinical study titled "A Study of HIV in Newly Infected Individuals". The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. The...

What is the current status of trial NCT00000930?

This trial is currently completed. Estimated completion is 2008-05.

What conditions does trial NCT00000930 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00000930?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000930 being conducted?

This trial has 12 study locations across California, Colorado, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.